Curis (CRIS) to Release Quarterly Earnings on Thursday

Curis (NASDAQ:CRIS) is projected to announce its earnings results before the market opens on Thursday, February 13th. Analysts expect the company to announce earnings of ($1.36) per share and revenue of $2.04 million for the quarter.

Curis Price Performance

Shares of CRIS opened at $3.22 on Tuesday. The firm has a 50 day simple moving average of $3.46 and a 200-day simple moving average of $4.44. Curis has a 1-year low of $2.86 and a 1-year high of $17.49. The stock has a market cap of $27.27 million, a price-to-earnings ratio of -0.41 and a beta of 3.41.

Analyst Upgrades and Downgrades

Separately, HC Wainwright reissued a “buy” rating and issued a $20.00 price target on shares of Curis in a report on Tuesday, December 10th.

Curis Company Profile

Curis, Inc, a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule IRAK4 kinase inhibitor, which is in a Phase 1/2 open-label, single arm expansion trial in patients with relapsed or refractory, or R/R, AML and high-risk myelodysplastic syndromes.